Envveno Medical Corp (NVNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,472 | -15,736 | -11,197 | -4,503 | -21,819 |
| Depreciation Amortization | 489 | 372 | 252 | 122 | 528 |
| Accounts payable and accrued liabilities | 1 | 383 | 907 | -440 | 698 |
| Other Working Capital | -396 | 144 | 844 | -482 | 290 |
| Other Operating Activity | 3,810 | 2,712 | 1,461 | 1,285 | 3,465 |
| Operating Cash Flow | $-15,568 | $-12,125 | $-7,733 | $-4,018 | $-16,838 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -5 | -5 | N/A | -37 |
| Purchase Of Investment | -46,018 | -26,702 | -16,807 | -8,874 | -55,567 |
| Sale Of Investment | 61,879 | 38,381 | 24,835 | 14,075 | 56,939 |
| Investing Cash Flow | $15,856 | $11,674 | $8,023 | $5,201 | $1,335 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,023 | 241 | 0 | 0 | 13,637 |
| Financing Cash Flow | $1,023 | $241 | $N/A | $0 | $13,637 |
| Beginning Cash Position | 1,754 | 1,754 | 1,754 | 1,754 | 3,620 |
| End Cash Position | 3,065 | 1,544 | 2,044 | 2,937 | 1,754 |
| Net Cash Flow | $1,311 | $-210 | $290 | $1,183 | $-1,866 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,568 | -12,125 | -7,733 | -4,018 | -16,838 |
| Capital Expenditure | -5 | -5 | -5 | N/A | -37 |
| Free Cash Flow | -15,573 | -12,130 | -7,738 | -4,018 | -16,875 |